The Director will lead commercialization workstreams for polysaccharides, facilitating launch readiness and commercial supply while coordinating cross-functional efforts across regulatory, quality, and manufacturing teams. This role provides strategic leadership to ensure robust manufacturing processes and effective communication of scientific rationale to internal stakeholders and regulatory agencies.
Lead the development of digital infrastructure, AI capabilities, and the commercial technology roadmap for the launch of VAX-31. Act as a strategic enabler across Marketing, Sales, Medical Affairs, and Market Access to reduce friction and increase operational leverage.
Lead enterprise-wide efforts to structure, govern, and utilize data and knowledge assets to support process development, clinical, and regulatory activities. Establish systems to capture institutional knowledge and ensure data integrity for commercial regulatory submissions.
